Delivery Order SPE2DB20D3101-SPE2DB23FRPD1
- Not listed
- This federal contract award is for the delivery of Advair HFA 230-21 MCG inhalers to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,720.28, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA, valued at up to $999,999,999, which runs through November 2026. This IDC...
- This federal contract award, valued at $2,801.77, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of an Advair HFA 115-21 MCG Inhaler, a pharmaceutical product. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle...
- This federal contract award is for the delivery of Advair HFA 115-21 MCG Inhaler 12GM pharmaceutical products to the Defense Logistics Agency (DLA). The single-award Indefinite Delivery Contract (IDC) with the prime contractor, Amerisourcebergen Drug Corp, is valued at up to $999,999,999.00 and runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Advair HFA 115-21 mcg inhalers. The single award Indefinite Delivery Contract (IDC) is valued at up to $999,999,999.00 through December 31, 2025 and serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of...
- This federal contract award is for the delivery of Advair HFA 230-21 MCG Inhaler 12GM to the Medical Supply Chain division of the Defense Logistics Agency (DLA). The $11,217.14 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. This contract does not have a set-aside designation. The award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support...
- The federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Advair HFA 115-21 MCG Inhaler 12GM to the Defense Logistics Agency (DLA). The Firm Fixed Price delivery order, valued at $4,701.81, has an ultimate completion date of March 1, 2024. This contract is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC enables...
- This federal contract award is for the delivery of Advair HFA 45-21 MCG Inhaler 12GM, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $10,623.38 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation, through its Corporate Office division located in Conshohocken, Pennsylvania. This order is part of a larger indefinite delivery contract...
- This federal contract award is for the delivery of Advair HFA 115-21 MCG inhalers, valued at $3,231.96, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a...
- This federal contract award, valued at $2,687.99, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Advair HFA 115-21 MCG Inhaler 12GM, a pharmaceutical product, with a completion date of June 13, 2024. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
- This federal contract award is for the delivery of Advair HFA 115-21 MCG Inhaler 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,939.04 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., which is a major pharmaceutical distribution company. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 between Cencora, Inc. and the DLA Troop Support Medical, which serves as the...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB23FRPD1Delivery Order
This federal contract award is for the delivery of pharmaceutical products, specifically Advair HFA 115-21 MCG Inhaler, to the Defense Logistics Agency (DLA). The contract, valued at $2,208.84, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and subsidiary of Cencora, Inc. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition. This contract is part of Amerisourcebergen's broader efforts to serve as a critical supplier of essential medical commodities to various federal agencies, including the Department of Defense and Department of Justice.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 6/12/23 |